"For over 20 years, TACE has been the standard treatment for intermediate-stage HCC, but its efficacy has been limited," said Dr. Llovet, who is Director of Mount Sinai's Liver Cancer Program and ...

More information: Souha H. Youssef et al, Printing a cure: A tailored solution for localized drug delivery in liver cancer treatment, International Journal of Pharmaceutics (2024). DOI: 10.1016/j ...

Scientists at University of California San Diego School of Medicine have shed new light on the development of liver cancer, the sixth most frequently diagnosed cancer and fourth leading cause of ...

In addition to opening these new avenues of treatment for liver cancer, the study also offers new insight into the relationship between aging and cancer. "We know that aging increases the risk of ...

the researchers are hopeful that UDCA could be incorporated into liver cancer treatment plans to make immunotherapy more effective for these patients. The findings, published in Science ...

the researchers are hopeful that UDCA could be incorporated into liver cancer treatment plans to make immunotherapy more effective for these patients. The findings, published in Science on January ...

Long classified as a subset of common liver cancer, FLC should be considered ... a clinical trial to test the pairing of two anti-cancer medications, DT2216 and irinotecan, that the lab's earlier ...

Chemotherapy uses anti cancer (cytotoxic) drugs to destroy cancer cells. Chemoembolisation is a treatment directly into the liver. You have chemotherapy into the blood vessel that feeds the tumour.

Consultant radiologist Nadeem Shaida believes artificial intelligence will improve treatment for liver cancer patients Artificial intelligence (AI) is being used to improve a treatment for liver ...